Literature DB >> 16002024

Are judicial status hearings a "key component" of drug court? Six and twelve months outcomes.

Douglas B Marlowe1, David S Festinger, Karen L Dugosh, Patricia A Lee.   

Abstract

Substantial evidence indicates that drug courts can be superior to traditional probation programs for enhancing treatment retention and reducing substance use and crime among drug offenders. Few studies have isolated the effects of the hypothesized "key components" of drug courts to determine their contributions to outcomes. This article presents outcomes at 6 and 12 months post-admission for misdemeanor drug court clients who were randomly assigned to different dosages of judicial status hearings. Although earlier work revealed superior during-treatment effects for high-risk participants who were assigned to more frequent bi-weekly hearings, those effects did not extend post-treatment. The results did reveal significant pre-to-post improvements for participants, as a whole, in self-reported drug use, alcohol use, and criminal recidivism; however, lacking a no-drug court control condition, it is not possible to discern the magnitude of the effect of the drug court program. Approximately, half of the participants resumed drug or alcohol use within 12 months of admission to drug court, and approximately 10-15% resumed illegal activities. These findings lend credence to the potential effectiveness of drug courts; however, continuing-care strategies are required to extend the effects of drug courts beyond the initial active phases of the program.

Entities:  

Mesh:

Year:  2005        PMID: 16002024     DOI: 10.1016/j.drugalcdep.2005.01.019

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  11 in total

1.  Treatment retention among African-Americans in the Dane County Drug Treatment Court.

Authors:  Randall T Brown; Megan Zuelsdorff
Journal:  J Offender Rehabil       Date:  2009-05

2.  Adapting judicial supervision to the risk level of drug offenders: discharge and 6-month outcomes from a prospective matching study.

Authors:  Douglas B Marlowe; David S Festinger; Karen L Dugosh; Patricia A Lee; Kathleen M Benasutti
Journal:  Drug Alcohol Depend       Date:  2006-10-30       Impact factor: 4.492

3.  Matching Judicial Supervision to Clients' Risk Status in Drug Court.

Authors:  Douglas B Marlowe; David S Festinger; Patricia A Lee; Karen L Dugosh; Kathleen M Benasutti
Journal:  Crime Delinq       Date:  2006

4.  Adaptive Interventions in Drug Court: A Pilot Experiment.

Authors:  Douglas B Marlowe; David S Festinger; Patricia L Arabia; Karen L Dugosh; Kathleen M Benasutti; Jason R Croft; James R McKay
Journal:  Crim Justice Rev       Date:  2008

5.  Associations with substance abuse treatment completion among drug court participants.

Authors:  Randall Brown
Journal:  Subst Use Misuse       Date:  2010-10       Impact factor: 2.164

6.  Outcome Trajectories in Drug Court: Do All Participants Have Drug Problems?

Authors:  David Dematteo; Douglas B Marlowe; David S Festinger; Patricia L Arabia
Journal:  Crim Justice Behav       Date:  2009-04

7.  Impact of jail sanctions during drug court participation upon substance abuse treatment completion.

Authors:  Randall T Brown; Paul A Allison; F Javier Nieto
Journal:  Addiction       Date:  2011-01       Impact factor: 6.526

Review 8.  Penn/VA center for studies of addiction.

Authors:  Charles P O'Brien; A Thomas McLellan; Anna Rose Childress; George E Woody
Journal:  Neuropharmacology       Date:  2008-06-26       Impact factor: 5.250

9.  Adaptive Programming Improves Outcomes in Drug Court: An Experimental Trial.

Authors:  Douglas B Marlowe; David S Festinger; Karen L Dugosh; Kathleen M Benasutti; Gloria Fox; Jason R Croft
Journal:  Crim Justice Behav       Date:  2012-04-01

Review 10.  The impact of drug treatment courts on recovery: a systematic review.

Authors:  Ciska Wittouck; Anne Dekkers; Brice De Ruyver; Wouter Vanderplasschen; Freya Vander Laenen
Journal:  ScientificWorldJournal       Date:  2013-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.